Omlan, Cherie .
HRN: 25-57-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/05/2026
02/11/2026
IV
80mg
Q6
Impetigo; Dermatitis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: